The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screening market size has experienced swift expansion in recent years. It is projected to increase from $6.98 billion in 2025 to $7.84 billion in 2026, at a compound annual growth rate (CAGR) of 12.3%. This historical growth can be attributed to the broadening of public health screening initiatives, a rise in institutional births, the accessibility of neonatal care facilities, an increasing focus on early disease identification, and enhancements in diagnostic testing coverage.
The prenatal testing & newborn screening market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $12.22 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.8%. This expansion during the forecast period is driven by the increasing implementation of national screening mandates, the rising embrace of digital diagnostic platforms, growing financial commitments to maternal and child healthcare, a heightened focus on preventive healthcare models, and the expanding application of AI-assisted diagnostics. Significant trends during this period are expected to include the increasing integration of prenatal and newborn screening programs, a rise in the use of combined screening and diagnostic technologies, the wider adoption of early intervention protocols, the scaling up of automated screening workflows, and an intensified focus on comprehensive, population-wide screening.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
Which Significant Factors Are Encouraging Growth In The Prenatal Testing & Newborn Screening Market?
The significant occurrence of genetic disorders in babies has played a role in expanding the prenatal testing & newborn screening market. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Sickle cell anemia is a widespread genetic condition impacting millions globally, especially prevalent in populations with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study conducted at Rady Children’s Hospital, as reported by the US-based Rady Children’s Institute for Genomic Medicine in February 2023, revealed that 41% of infant fatalities were due to single-locus (Mendelian) genetic disorders. This elevated incidence of genetic conditions in infants has spurred the demand for the prenatal testing and newborn screening market.
How Are Different Segment Groups Identified Within The Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screening market covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End User: Hospitals, Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis
Which Trends Are Expected To Shape The Prenatal Testing & Newborn Screening Market?
Leading companies within the prenatal DNA sequencing market are adopting a strategic alliance approach to enhance the integration of technology and expand their market reach. A strategic partnership typically signifies a collaborative relationship among two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For instance, in December 2023, BillionToOne, a US-based precision diagnostics company, formed a partnership with a Johnson & Johnson company, a US-based pharmaceutical company, for the AZALEA Phase 3 clinical trial concerning nipocalimab. This trial focuses on pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). BillionToOne will provide its UNITY Fetal Antigen Non-invasive Prenatal Test (UNITY Fetal Antigen CTA) to screen participants and determine their eligibility. HDFN is a rare condition caused by blood type incompatibility between the pregnant individual and the fetus, potentially leading to life-threatening anemia.
Who Are The Key Market Participants In The Prenatal Testing & Newborn Screening Market?
Major companies operating in the prenatal testing & newborn screening market are PerkinElmer Inc, Laboratory Corporation Of America Holdings, Natera Inc, Invitae Corporation, Centogene AG, Cradle Genomics Inc, Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc, Progenity Inc, Ravgen Inc, Strand Life Sciences Pvt Ltd, Eurofins Scientific, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Siemens Healthineers AG, BGI Group, QIAGEN NV, Ariosa Diagnostics Inc, Verinata Health Inc, Counsyl A Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid A Danaher Company
Access The Complete Prenatal Testing & Newborn Screening Market Report:
Which Geographic Region Represents The Largest Prenatal Testing & Newborn Screening Market Share?
North America was the largest region in the prenatal testing & newborn screening market in 2025. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Prenatal Testing & Newborn Screening Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp
Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2026, By The Business Research Company
Dna Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Protein Sequencing Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
